Clinical Trials Logo

Lumbar Spine Degeneration clinical trials

View clinical trials related to Lumbar Spine Degeneration.

Filter by:
  • Recruiting  
  • Page 1

NCT ID: NCT06154005 Recruiting - Clinical trials for Degenerative Disc Disease

OsteoAdapt SP Advanced Bone Graft Feasibility Study - Transforaminal Interbody Lumbar Fusion

OASIS
Start date: May 1, 2024
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this clinical study is to assess the safety and effectiveness of the OsteoAdapt SP as a replacement for the autograft standard of care bone graft within the interbody cage, as well as identify the OsteoAdapt SP dose to be investigated in a future pivotal study.

NCT ID: NCT05746143 Recruiting - Pain, Postoperative Clinical Trials

The Effect of Zolpidem on Outcomes Following Lumbar Spine Fusion

Start date: February 1, 2022
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate if peri-operative zolpidem for posterior lumbar spinal fusion improves patient reported outcomes following surgery.

NCT ID: NCT05527145 Recruiting - Clinical trials for Lumbar Spinal Stenosis

Spinal Stenosis and Listhesis Treated With Percutaneous Interspinous Spacer: a Non-surgical Trial

Start date: September 2024
Phase: N/A
Study type: Interventional

Symptomatic lumbar spinal stenosis is the most common indication for spinal surgery. However, more than one-third of the patients undergoing surgery for lumbar stenosis report dissatisfaction with the results. On the other hand, conservative treatment has shown positive results in some cases. This trial will compare the outcomes of surgical versus non-surgical treatment for lumbar stenosis.

NCT ID: NCT05452694 Recruiting - Clinical trials for Lumbar Spine Degeneration

OpalGenix- Personalized Postoperative Pain Management Following Lumbar Spinal Fusion and Decompression Surgery in Adults

Start date: November 1, 2022
Phase:
Study type: Observational

The proposed research is an important extension of an ongoing perioperative personalized analgesia and intravenous opioid pharmacogenetic research. This research focuses on two of the most commonly used oral opioid analgesics, oxycodone, and methadone, in adults following lumbar spinal fusion and decompression surgery. Genetic signature and combinatorial pharmacogenetic approaches perform better than single-gene associations. This innovative translational research will for the first time evaluate simultaneously the effects of multiple genes and interactions on oxycodone and methadone's pharmacokinetics and optimal clinical dosing and on its safety and efficacy in the highly vulnerable pediatric population. This research's multigenetic signature findings can be easily extrapolated to adults undergoing surgery or using oxycodone and/or methadone for chronic and cancer pain and in identifying opioid abusers at risk of severe respiratory depression and death. When methadone is given in addition to oxycodone for inpatient pectus excavatum repair and idiopathic scoliosis spinal fusions according to new departmental protocols, methadone pharmacokinetics and pharmacodynamics will also be evaluated.

NCT ID: NCT05438719 Recruiting - Clinical trials for Lumbar Spine Degeneration

MOTUS Total Joint Replacement Investigational Device Exemption Study

Start date: June 20, 2022
Phase: N/A
Study type: Interventional

This study is designed to collect safety and efficacy data on patients who plan to undergo a single-level total joint replacement of the lumbar spine using the MOTUS device (MOTUS Total Joint Replacement procedure) to demonstrate noninferiority to lumbar interbody fusion with respect to composite endpoints.

NCT ID: NCT04823858 Recruiting - Clinical trials for Lumbar Spine Degeneration

3Spine Lumbar Fusion Real World Evidence Study

Start date: May 25, 2021
Phase:
Study type: Observational [Patient Registry]

This study is designed to collect real world evidence (RWE) safety and efficacy data on patients who plan to undergo a single-level Transforaminal lumbar interbody fusion (TLIF) or Posterior lumbar interbody fusion (PLIF) instrumented with pedicle screws, using the framework of a prospective clinical study (with defined enrollment criteria and pre-specified research follow-up timepoints).

NCT ID: NCT04781517 Recruiting - Clinical trials for Lumbar Spine Degeneration

Development of a Patient-reported Outcome Instrument for Patients With Lumbar Degenerative Disease After Lumbar Fusion

DPROIPLDDALF
Start date: May 1, 2020
Phase:
Study type: Observational

The commonly used scales (ODI+JOA-29+VAS) lack the assessment of lumbar stiffness, and there is no scale for evaluating lumbar stiffness in China.Based on the Delphi method and the analytic hierarchy process, this study will improve and optimize the quality of life evaluation system for patients with severe degenerative lumbar disease, so as to obtain a concise, practical, and effective patient-reported outcome instrument.

NCT ID: NCT04140344 Recruiting - Clinical trials for Lumbar Spine Degeneration

The NOTICE Study: Neurosurgery and OrThopedIcs Communication Evaluation Study Following Lumbar Fusions

NOTICE
Start date: September 7, 2023
Phase: N/A
Study type: Interventional

The purpose of this single-blind, randomized, controlled study is to assess the efficacy of "informative text messages" vs "traditional handouts" provided to lumbar spine surgery patients post-operatively.